CLBK Stock Analysis: Columbia Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 3.024m USD | 12M Return: 62.9% | US1979141041 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 31.9M
EPS Trend: 74.0%
Qual. Beats: 2
Rev. Trend: 86.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 8.6 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Columbia Financial, Inc. (CLBK) is a bank holding company that operates Columbia Bank, providing commercial, residential, and consumer loans, along with deposit products, title insurance, wealth management, and cash management services. The company is headquartered in Fair Lawn, New Jersey, and operates full-service banking offices throughout the state. Founded in 1926, Columbia Financial went public in 2018 following its conversion from a mutual holding company structure (formerly a subsidiary of Columbia Bank MHC), a transition commonly used by community banks transitioning to public ownership.
- Net interest margin compresses amid rising deposit costs
- Commercial real estate loan portfolio faces credit risk
- Multifamily lending growth drives loan portfolio expansion
| Net Income: 48.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.09 > 1.0 |
| NWC/Revenue: -1.47k% < 20% (prev -1.53k%; Δ 57.70% < -1%) |
| CFO/TA 0.01 > 3% & CFO 96.8m > Net Income 48.5m |
| Net Debt (-2.70b) to EBITDA (67.3m): -40.04 < 3 |
| Current Ratio: 0.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (251.7m) vs 12m ago 12.11% < -2% |
| Gross Margin: 52.61% > 18% (prev 44.50%; Δ 8.11% > 0.5%) |
| Asset Turnover: 3.89% > 50% (prev 4.30%; Δ -0.41% > 0%) |
| Interest Coverage Ratio: 0.19 > 6 (EBIT TTM 49.0m / Interest Expense TTM 257.7m) |
| A: -0.46 (Total Current Assets 4.47b - Total Current Liabilities 12.6b) / Total Assets 17.6b |
| B: 0.05 (Retained Earnings 953.6m / Total Assets 17.6b) |
| C: 0.00 (EBIT TTM 49.0m / Avg Total Assets 14.2b) |
| D: 0.22 (Book Value of Equity 3.17b / Total Liabilities 14.4b) |
| Altman-Z'' = -2.62 = D |
| DSRI: 1.35 (Receivables 67.7m/42.2m, Revenue 553.4m/466.9m) |
| GMI: 0.85 (GM 44.50% / 52.61%) |
| AQI: 0.83 (AQ_t 0.74 / AQ_t-1 0.89) |
| SGI: 1.19 (Revenue 553.4m / 466.9m) |
| TATA: -0.00 (NI 48.5m - CFO 96.8m) / TA 17.6b) |
| Beneish M = -2.84 (Cap -4..+1) = A |
As of November 20, 2026, the stock is trading at USD 10.82 with a total of 3,084,099 shares traded. Over the past week, the price has changed by -3.57%, over one month by +2.82%, over three months by -7.03% and over the past year by +62.94%.
Current recommended Stop Loss: 10.40 (which is 3.9% or 1.7 ATR below the current price).
Columbia Financial has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy CLBK.
- StrongBuy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.2 | 31% |
P/E Trailing = 37.4
P/E Forward = 72.4638
P/S = 10.9867
P/B = 0.9661
Revenue TTM = 553.4m USD
EBIT TTM = 49.0m USD
EBITDA TTM = 67.3m USD
Long Term Debt = 1.50b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.70b USD (calculated: Debt 1.50b - CCE 4.19b)
Enterprise Value = 328.0m USD (3.02b + Debt 1.50b - CCE 4.19b)
Interest Coverage Ratio = 0.19 (Ebit TTM 49.0m / Interest Expense TTM 257.7m)
EV/FCF = 3.72x (Enterprise Value 328.0m / FCF TTM 88.2m)
FCF Yield = 26.88% (FCF TTM 88.2m / Enterprise Value 328.0m)
FCF Margin = 15.93% (FCF TTM 88.2m / Revenue TTM 553.4m)
Net Margin = 8.77% (Net Income TTM 48.5m / Revenue TTM 553.4m)
Gross Margin = 52.61% ((Revenue TTM 553.4m - Cost of Revenue TTM 262.2m) / Revenue TTM)
Gross Margin QoQ = 55.18% (prev 51.47%)
Tobins Q-Ratio = 0.02 (Enterprise Value 328.0m / Total Assets 17.6b)
Interest Expense / Debt = 17.23% (Interest Expense 257.7m / Debt 1.50b)
Taxrate = 18.96% (11.4m / 59.9m)
NOPAT = 39.7m (EBIT 49.0m * (1 - 18.96%))
Current Ratio = 0.35 (Total Current Assets 4.47b / Total Current Liabilities 12.6b)
Debt / Equity = 0.47 (Debt 1.50b / totalStockholderEquity, last quarter 3.17b)
Debt / EBITDA = -40.04 (Net Debt -2.70b / EBITDA 67.3m)
Debt / FCF = -30.59 (Net Debt -2.70b / FCF TTM 88.2m)
Total Stockholder Equity = 1.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.34% (Net Income 48.5m / Total Assets 17.6b)
RoE = 2.90% (Net Income TTM 48.5m / Total Stockholder Equity 1.67b)
RoCE = 1.55% (EBIT 49.0m / Capital Employed (Equity 1.67b + L.T.Debt 1.50b))
RoIC = 0.81% (NOPAT 39.7m / Invested Capital 4.91b)
WACC = 9.30% (E(3.02b)/V(4.52b) * Re(7.0%) + D(1.50b)/V(4.52b) * Rd(17.23%) * (1-Tc(0.19)))
Discount Rate = 7.0% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 49.83 | Cagr: 5.39%
[DCF] Terminal Value 74.94% ; FCFF base≈78.4m ; Y1≈89.9m ; Y5≈132.3m
[DCF] Fair Price = 16.33 (EV 1.70b - Net Debt -2.70b = Equity 4.40b / Shares 269.5m; r=9.30% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 73.95 | EPS CAGR: 55.01% | SUE: 0.88 | # QB: 2
Revenue Correlation: 86.32 | Revenue CAGR: 7.25% | SUE: 0.77 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.17 | Chg30d=-7.39% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=0.51 | Chg30d=-16.31% | Revisions=+25% | GrowthEPS=+117.0% | GrowthRev=+62.8%
EPS next Year (2027-12-31): EPS=0.74 | Chg30d=-4.32% | Revisions=+25% | GrowthEPS=+43.5% | GrowthRev=+43.1%
[Analyst] Revisions Ratio: +50% (up=3, down=0)